Home Depot on Tuesday reported better-than-expected fourth-quarter results, but high interest rates continue to cloud its outlook for the year. Net sales in the three months ended Feb. 2 rose 14.1% to $39.7 billion, topping estimates of $39.16 billion, according to LSEG. Earnings per share (EPS) increased 6.7% on...
Things continue to look up for GE Healthcare stock this year. Shares of the medical technology company jumped roughly 9% on Thursday after delivering solid fourth-quarter results and providing prudent 2025 guidance. While the Club stock left much to be desired in 2024, these numbers boosted shares that were...
Eli Lilly on Thursday reminded investors that the best growth story in large-cap pharmaceuticals has hardly grown stale, sending shares to their highest levels since October. Revenue in the three months ended Dec. 31 rose 45% year over year to $13.53 billion, in line with Wall Street expectations, according...
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer's faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts' estimates...
The rejuvenated Disney kept rolling Wednesday, delivering first-quarter results that beat expectations alongside reasons for optimism in the year ahead. Revenue in the three months ended Dec. 31 rose 5% on an annual basis to $24.69 billion, topping expectations of $24.62 billion, according to estimates compiled by LSEG. Adjusted...
BlackRock reported better-than-expected earnings Wednesday, lifting shares of the asset management giant higher as it embarks on a pivotal year of expansion into fast-growing markets. Revenue of $5.68 billion in the three months ended Dec. 31 exceeded expectations of $5.49 billion, according to LSEG. Adjusted earnings per share (EPS)...
Shares of troubled Nextracker jumped Thursday, the morning after delivering strong quarterly results and increases to the solar company's full-year profitability outlook and project backlog. Revenue in its fiscal 2025 second quarter totaled $635.6 million, up nearly 11% year over year and ahead of the consensus estimate of $615.4...
Returning soon to a Starbucks near you: Ceramic mugs, Sharpies on cups and the condiment bar to add your own cream and sugar. Those were just some of the details that Brian Niccol shared Wednesday night on his first earnings call since taking over as CEO of the struggling...
Eli Lilly shares fell Wednesday after the diabetes-and-obesity drug giant posted disappointing third-quarter results and lowered its full-year sales guidance. The report was messy, but it doesn't dim Eli Lilly's bright multiyear outlook, rendering the dip in the stock as a chance to buy. Revenue in the three months...
Dover on Thursday reported weaker-than-expected third-quarter results, pressuring shares of the industrial conglomerate with ties to AI data centers. We're not concerned: The company's recent asset sales is likely causing some confusion about the numbers. Revenue rose 1.3% year over year to $1.98 billion, a tad shy of the...